Close
Close
Treatment Database
Recombinant human C1-esterase inhibitor
Trade Name not avaiable
Orphan Indication Prophylactic treatment of angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency
USA Market Approval
USA Designation Date 23-02-1999
Sponsor Pharming Group N.V.
P. O. Box 451 Darwinweg 24, 2300 Al Leiden
Leiden
More about Hereditary angioedema
Free Newsletter
Related Videos
by Abidemi Uruejoma
260 views
by Abidemi Uruejoma
580 views
by Abidemi Uruejoma
578 views
by Abidemi Uruejoma
859 views
by Abidemi Uruejoma
4,478 views